Pratap Khanwilkar

Four decades of transformational contributions and leadership in innovative medical technology advancement including innovation and commercialization. 4 breakthrough technologies advanced to help patients in cardiac, neurologic, orthopedic and drug delivery: 1) Fully maglev centrifugal long-term implantable LVADs (Left Ventricular Assist Devices) for late-stage heart failure- from concept to European First-In-Human clinical studies, US pivotal clinical trial for Bridge-To-Transplant and revenue generation. Founder/CEO of Salt Lake City-based start-up, MedQuest Products, with acquisition by NASDAQ: WHRT, TSX: WHT. 2) Next-generation long-term implantable neuromodulator allowing simultaneous blocking and stimulation w/o interference, a breakthrough with benchtop prototype productized through in vivo tests, human cadaver studies, controlled manufacturing and verification and validation leading to FDA Early Feasibility Study (EFS) IDE submitted. Founder/CEO of start-up Miran Medical. 3) Bioresorbable Magnesium alloy based orthopedics: These prevent the need for re-surgeries when Titanium and Stainless steel alloys are implanted to fix a fracture and then need to be explanted with a follow-on surgery. Advised and managed industry/business focus for NSF Engineering Research Center. Plates and screws based on resorbable Mg are now commercialized by 2 companies in Germany and 1 in the US. 4) Oral delivery of biological drugs: A 'holy grail' of pharma, part of leadership team at medtech incubator InCube Labs LLC, which incubated Rani Therapeutics and took it public on NASDAQ for > $500MM market cap in July 2021. Contributed to the early clinical studies of the Rani Pill to demonstrate proof of concept for this never-done-before drug delivery platform. 18 start-ups, 3 exits, >$500MM raised in non-dilutive/dilutive funding. Founder/CEO, CTO and Board Chair to Public Company Officer and Angel Investor. Team formation, organizational development and ecosystem advancement worldwide creating and coaching leaders in USA, Europe, China, Japan, Canada, South Korea, Australia, and India. Research Interests: Biomedical engineering Electronics, sensors and digital hardware Control engineering, mechatronics and robotics Cardiovascular medicine and haematology

Cai, H., Morgan, T., Pace, N., Shen, B., Wang, J., Roppolo, J.R., Horlen, K., Khanwilkar, P., de Groat, W.C., & Tai, C. (2019). Low pressure voiding induced by a novel implantable pudendal nerve stimulator. Neurourol Urodyn , 38(5), 1241-1249.Wiley. doi: 10.1002/nau.23994 . Kumar, A., & Khanwilkar, P.S. (2011). Long-term implantable Ventricular Assist Devices (VADs) and Total Artificial Hearts (TAHs). In Comprehensive Biomaterials . 6, (pp. 389-401).Elsevier. Bearnson, G.B., Jacobs, G.B., Kirk, J., Khanwilkar, P.S., Nelson, K.E., & Long, J.W. (2006). HeartQuest ventricular assist device magnetically levitated centrifugal blood pump. Artif Organs , 30(5), 339-346.Wiley. doi: 10.1111/j.1525-1594.2006.00223.x . Borovetz, H.S., Badylak, S., Boston, J.R., Johnson, C., Kormos, R., Kameneva, M.V.